Althea Group Holdings Limited

AGH

AU0000022774

Pharmaceuticals

Market Closed - Australian S.E. Other stock markets 05:41:08 17/07/2024 BST			5-day change	1st Jan Change
0.024 ^AUD	+4.35%		-17.24%	-38.46%

07-16	Althea Group Raises AU$2 Million via Placement; Shares Plunge 23%	MT
07-10	Althea Introduces Medicinal Cannabis Flower Range to Market	MT

Althea Group Holdings Limited announced that it has received CAD 2.5 million in funding from Aphria Inc.

January 14, 2018

Althea Group Holdings Limited (ASX:AGH) announced that it has received CAD 2.5 million in an equity round of funding from new investor Aphria Inc. (TSX:APH) on January 15, 2018. Investor had acquired 25% stake in the company.

Latest news about Althea Group Holdings Limited

Althea Group Raises AU$2 Million via Placement; Shares Plunge 23%	07-16	MT
Althea Introduces Medicinal Cannabis Flower Range to Market	07-10	MT
Althea Group Holdings Signs JV to Enter US Cannabis-Infused Drinks Market	05-23	MT
Althea Group Signs Supply Agreement with Rocket Factory	05-23	MT
Althea Group Holdings Posts AU$8 Million in Cash Receipts in Fiscal Q3	04-30	MT
Althea Group Signs Distribution Agreement with Symbion	04-22	MT
Althea Group Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-29	CI
European yields rise, Italy's 10-year yield bounces off three-week low	02-26	RE
European yields tick up, Italy's 10-year yield bounces off three-week low	02-26	RE
IT, Real Estate Rally Drives Rebound in Australian Shares	02-02	MT
Althea Group Subsidiary Peak Signs Manufacturing Deal with Collective Project; Shares Up 8%	02-01	MT
Markets stumble into rate-cut waiting room as central banks stand firm	02-01	RE
Hong Kong court convicts four for rioting after 2019 legislature storming	02-01	RE
Althea Group Posts 33% Jump in Fiscal Q2 Receipts from Customers	01-31	MT
Higher Spanish inflation kicks euro zone bond yields off two-week lows	01-30	RE
Althea Group Launches Two Softgel Cannabis Capsules; Shares Up 5%	01-23	MT
Euro zone bond yields drop as economic gloom thickens	12-13	RE
Italian debt in the spotlight as ratings reviews loom	18/10/23	RE
Althea Group to Sell, Lease Back Canada Property for AU$5.3 Million	17/10/23	MT
Euro zone bond yields drop on Middle East conflict	09/10/23	RE
Middle East turmoil ratchets up uncertainty for battered markets	09/10/23	RE
Euro zone bond yields slip ahead of U.S. data	05/10/23	RE
Euro zone bond rout continues as Treasury yields surge to 2007 levels	04/10/23	RE
Italy bond yields surge after budget; German 10-year hits 12-year high	28/09/23	RE
Euro zone bond yields hover near 2-week high on renewed inflation fears	06/09/23	RE

Chart Althea Group Holdings Limited

Duration

Period

More charts

Company Profile

Althea Group Holdings Limited is engaged in the manufacturing, sales and distribution of recreational cannabis products and cannabis-based medicines. The Company operates through three business units: Althea, MyAccess Clinics and Peak Processing Solutions. Althea and MyAccess Clinics service the international pharmaceutical cannabis market, whilst Peak Processing Solutions operates in the federally legal Canadian recreational cannabis market. The Companyâs segments include the international pharmaceutical segment (Pharmaceutical Cannabis), the Canadian recreational segment (Recreational Cannabis) and the shared corporate services (Corporate). The Pharmaceutical Cannabis includes Althea, a brand of cannabis-based medicine. The Companyâs Recreational Cannabis segment includes Peak Processing Solutions (Peak), a contract manufacturing organization which works with consumer-packaged goods companies to develop, manufacture, and distribute recreational cannabis products.

Sector

Pharmaceuticals

Calendar

28/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ALTHEA GROUP HOLDINGS LIMITED	-38.46%	6.35M
ELI LILLY AND COMPANY	+56.75%	848B
NOVO NORDISK A/S	+33.10%	627B
JOHNSON & JOHNSON	-0.10%	363B
MERCK & CO., INC.	+16.06%	318B
ABBVIE INC.	+12.86%	299B
ASTRAZENECA PLC	+15.32%	243B
NOVARTIS AG	+17.23%	225B
AMGEN INC.	+16.35%	179B
PFIZER, INC.	+5.17%	167B

Other Pharmaceuticals